Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CRMD
#2827
CorMedix Inc.
7.300
0
USD
-0.27%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.27%
Changement Mensuel
+12.65%
Evolution sur 6 mois
-35.40%
Changement Annuel
-35.40%
Clôture Précédente
7.320
0
Open
7.300
0
Bid
Ask
Low
7.300
0
High
7.300
0
Volume
62
Marchés
Actions des Marchés US
Soins de Santé
CRMD
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
38.02 M
38.73 M
44.5 M
54.98 M
65.18 M
79.05 M
—
Valuation ratios
Enterprise value
240.61 M
122.9 M
142.86 M
163.64 M
487.32 M
776.77 M
2.75 B
Price to earnings ratio
—
-0.02
-5.65
-4.14
-27
5.7
51.7
Price to sales ratio
—
2.27
2 573.79
—
10.97
0
15.47
Price to cash flow ratio
—
-0.02
-6.91
-5
-9.42
0.01
23.22
Price to book ratio
—
0.01
3.06
2.74
5.63
0
4.08
Enterprise value to EBITDA ratio
-8.88
-4.18
-4.68
-3.35
-22.1
4.32
50.66
Profitability ratios
Return on assets %
-0.45
-0.41
-0.48
-0.56
-0.15
0.2
0.38
Return on equity %
-0.5
-0.45
-0.54
-0.66
-0.21
0.4
0.59
Return on invested capital %
-12.93 K
-5 882.72
-4 602.58
-7 277.18
-457.82
241.19
602.25
Gross margin %
14.37
22
94.29
—
92.66
88.46
363.93
Operating margin %
-11.38 K
-15.42 K
-46.82 K
—
-51.43
48.17
195.89
EBITDA margin %
-11.32 K
-15.39 K
-46.69 K
—
-50.71
57.54
223.04
Net margin %
-9 207.7
-14.77 K
-45.41 K
—
-41.24
52.31
217.73
Liquidity ratios
Quick ratio
11.54
12.43
9.44
6.78
3.16
1.94
15.17
Current ratio
11.58
12.44
9.44
6.97
3.39
2.11
16.08
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0.43
0.66
0.86
Solvency ratios
Debt to assets ratio
—
—
—
—
—
0
—
Debt to equity ratio
—
—
—
—
—
0.01
—
Long term debt to total assets ratio
—
—
—
—
—
-0
—
Long term debt to total equity ratio
—
—
—
—
—
-0
—
Per share metrics
Operating cash flow per share
—
-222.02
-0.6
-0.75
-0.86
2 179.68
1 177.3
EBIT per share
—
-308.94
-0.76
-0.96
-0.38
2 042.3
865
EBITDA per share
—
-308.29
-0.76
-0.96
-0.37
2 233.4
1 041.44
Total debt per share
—
—
—
—
—
27.99
—
Cash per share
—
687.05
1.46
1.49
0.88
1 849.52
1 853.94
Net current asset value per share
—
697.57
1.48
1.56
1.95
4 570.54
4 579.1
Tangible book value per share
—
659.05
1.37
1.38
1.41
-46.91
-42.61
Working capital per share
—
641.48
1.32
1.34
1.37
2 400.53
2 406.6
Book value per share
—
659.05
1.37
1.38
1.44
5 046.91
5 055.98
Nouvelles
CorMedix: A Shrinking Core And No Proven Second Engine (NASDAQ:CRMD)
CorMedix: Waiting On Phase III ReSPECT For A Further Re-Rating (Upgrade) (NASDAQ:CRMD)
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength?
CorMedix à Citizens Life Sciences : expansion stratégique et croissance
CorMedix at Citizens Life Sciences: Strategic Expansion and Growth
CorMedix à la conférence Leerink : évolution stratégique et potentiel de marché
CorMedix at Leerink Conference: Strategic Evolution and Market Potential
Leerink réduit l’objectif de cours de CorMedix en raison d’ajustements de dépenses
Leerink cuts CorMedix stock price target on expense adjustments
Truist réitère sa recommandation sur l’action CorMedix malgré des prévisions stables
Truist reiterates CorMedix stock rating on steady guidance
CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript